Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer Patients (MBC)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02018419 |
Recruitment Status
:
Withdrawn
(changing indication from breast cancer to metastatic colorectal cancer)
First Posted
: December 23, 2013
Last Update Posted
: April 3, 2015
|
Sponsor:
Immunovative Therapies, Ltd.
Information provided by (Responsible Party):
Immunovative Therapies, Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : | Withdrawn |
---|---|
Estimated Primary Completion Date : | March 2016 |
Estimated Study Completion Date : | March 2017 |
Publications of Results: